Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10792)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 28, 2016 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bruha R, Jachymova M, Petrtyl J, Dvorak K, Lenicek M, Urbanek P, Svestka T, Vitek L. Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis. World J Gastroenterol 2016; 22(12): 3441-3450 [PMID: 27022226 DOI: 10.3748/wjg.v22.i12.3441] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i12/3441.htm |
| Number | Citing Articles |
| 1 |
Severin Donald Kamdem, Roger Moyou-Somo, Frank Brombacher, Justin Komguep Nono. Host Regulators of Liver Fibrosis During Human Schistosomiasis. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.02781
|
| 2 |
Élise Vuille-Lessard, Susana G. Rodrigues, Annalisa Berzigotti. Noninvasive Detection of Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease. Clinics in Liver Disease 2021; 25(2): 253 doi: 10.1016/j.cld.2021.01.005
|
| 3 |
XiaoHan Sun, Hong Bo Ni, Jian Xue, Shuai Wang, Afaf Aljbri, Liuchun Wang, Tian Hang Ren, Xiao Li, Meng Niu. Bibliometric-analysis visualization and review of non-invasive methods for monitoring and managing the portal hypertension. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.960316
|
| 4 |
Ramesh Rana, Shenglan Wang, Jing Li, Shiva Basnet, Liang Zheng, Changqing Yang. Diagnostic accuracy of non-invasive methods detecting clinically significant portal hypertension in liver cirrhosis: a systematic review and meta-analysis. Minerva Medica 2020; 111(3) doi: 10.23736/S0026-4806.19.06143-3
|
| 5 |
Sameer Gadani, Hans Michell, Shetal Shah, Sasan Partovi. Portal Pressure Measurements: Locations, Implications, and State of the Art. Digestive Disease Interventions 2022; 6(03): 249 doi: 10.1055/s-0042-1749644
|
| 6 |
Dmitry Victorovich Garbuzenko, Nikolay Olegovich Arefyev. Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis: An update and review of the literature. Journal of Evidence-Based Medicine 2020; 13(4): 313 doi: 10.1111/jebm.12407
|
| 7 |
Naaventhan Palaniyappan, Jonathan A. Fallowfield. Portal Hypertension VII. 2022; : 135 doi: 10.1007/978-3-031-08552-9_13
|
| 8 |
Praveen Sharma. Value of Liver Function Tests in Cirrhosis. Journal of Clinical and Experimental Hepatology 2022; 12(3): 948 doi: 10.1016/j.jceh.2021.11.004
|
| 9 |
Xiaolong Qi, Annalisa Berzigotti, Andres Cardenas, Shiv Kumar Sarin. Emerging non-invasive approaches for diagnosis and monitoring of portal hypertension. The Lancet Gastroenterology & Hepatology 2018; 3(10): 708 doi: 10.1016/S2468-1253(18)30232-2
|
| 10 |
Gyorgy Baffy. Origins of Portal Hypertension in Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences 2018; 63(3): 563 doi: 10.1007/s10620-017-4903-5
|
| 11 |
Jie Dong, Qiang Ma. Osteopontin enhances multi-walled carbon nanotube-triggered lung fibrosis by promoting TGF-β1 activation and myofibroblast differentiation. Particle and Fibre Toxicology 2017; 14(1) doi: 10.1186/s12989-017-0198-0
|
| 12 |
Rui Gaspar, Guilherme Macedo. Non-Invasive versus Invasive Assessment of Portal Hypertension in Chronic Liver Disease. GE - Portuguese Journal of Gastroenterology 2024; : 1 doi: 10.1159/000538484
|
| 13 |
Kateřina Žížalová, Barbora Nováková, Marek Vecka, Jaromír Petrtýl, Věra Lánská, Květa Pelinková, Václav Šmíd, Radan Brůha, Libor Vítek, Martin Leníček. Serum concentration of taurochenodeoxycholic acid predicts clinically significant portal hypertension. Liver International 2023; 43(4): 888 doi: 10.1111/liv.15481
|
| 14 |
Radan Bruha. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2016; : 1 doi: 10.1007/978-94-007-7742-2_44-1
|
| 15 |
Radan Bruha, Libor Vitek, Vaclav Smid. Osteopontin – A potential biomarker of advanced liver disease. Annals of Hepatology 2020; 19(4): 344 doi: 10.1016/j.aohep.2020.01.001
|
| 16 |
Patric Schyman, Richard L. Printz, Venkat R. Pannala, Mohamed Diwan M. AbdulHameed, Shanea K. Estes, Chiyo Shiota, Kelli Lynn Boyd, Masakazu Shiota, Anders Wallqvist. Genomics and metabolomics of early-stage thioacetamide-induced liver injury: An interspecies study between guinea pig and rat. Toxicology and Applied Pharmacology 2021; 430: 115713 doi: 10.1016/j.taap.2021.115713
|
| 17 |
Marzia Tagliaferro, Mariapaola Marino, Valerio Basile, Krizia Pocino, Gian Ludovico Rapaccini, Gabriele Ciasca, Umberto Basile, Valeria Carnazzo. New Biomarkers in Liver Fibrosis: A Pass through the Quicksand?. Journal of Personalized Medicine 2024; 14(8): 798 doi: 10.3390/jpm14080798
|
| 18 |
Ayman M. Fouad, Nagwa Ramadan Ahmed Hussein, Iman A. E. Shaheen, Mohammed A. Ismael. Usefulness of serum osteopontin level as a noninvasive parameter of portal hypertension. The Egyptian Journal of Internal Medicine 2019; 31(4): 502 doi: 10.4103/ejim.ejim_91_19
|
| 19 |
Jonathan Chung-Fai Leung, Thomson Chi-Wang Loong, James Pang, Jeremy Lok Wei, Vincent Wai-Sun Wong. Invasive and non-invasive assessment of portal hypertension. Hepatology International 2018; 12(S1): 44 doi: 10.1007/s12072-017-9795-0
|
| 20 |
Giuseppe Miceli, Grazia Pennisi, Luisa Agnello, Vincenza Calvaruso, Emanuele Amodio, Alessandra Casuccio, Chiara Pintus, Maria Grazia Basso, Rosaria Maria Pipitone, Mario Daidone, Rossella Zito, Giulia Lupo, Salvatore Petta, Giuseppe Cabibbo, Marcello Ciaccio, Stefania Grimaudo, Antonio CraxÌ, Antonino Tuttolomondo. Inflammation and autonomic balance in cirrhosis: Association between sympathetic nervous system and osteopontin, interleukin‐22, interleukin‐6 and interleukin‐1Ra concentrations according to portal hypertension and disease severity. Clinical and Translational Discovery 2023; 3(6) doi: 10.1002/ctd2.215
|
| 21 |
Mariia Lunova, Sona Frankova, Halima Gottfriedova, Renata Senkerikova, Magdalena Neroldova, Jozef Kovac, Eva Kieslichova, Vera Lanska, Eva Sticova, Julius Spicak, Milan Jirsa, Jan Sperl. Portal hypertension is the main driver of liver stiffness in advanced liver cirrhosis. Physiological Research 2021; : 563 doi: 10.33549/physiolres.934626
|
| 22 |
Radan Bruha. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; : 427 doi: 10.1007/978-94-007-7675-3_44
|
| 23 |
Susanne E Mortazavi, Allan Lugaajju, Mark Kaddumukasa, Muyideen Kolapo Tijani, Fred Kironde, Kristina E M Persson. Osteopontin and malaria: no direct effect on parasite growth, but correlation with P. falciparum-specific B cells and BAFF in a malaria endemic area. BMC Microbiology 2021; 21(1) doi: 10.1186/s12866-021-02368-y
|
| 24 |
S.M. Chooklin, S.S. Chuklin. Methods for assessing portal hypertension. EMERGENCY MEDICINE 2023; 19(6): 393 doi: 10.22141/2224-0586.19.6.2023.1618
|
| 25 |
Sona Frankova, Mariia Lunova, Halima Gottfriedova, Renata Senkerikova, Magdalena Neroldova, Jozef Kovac, Eva Kieslichova, Vera Lanska, Petr Urbanek, Julius Spicak, Milan Jirsa, Jan Sperl, Pavel Strnad. Liver stiffness measured by two-dimensional shear-wave elastography predicts hepatic vein pressure gradient at high values in liver transplant candidates with advanced liver cirrhosis. PLOS ONE 2021; 16(1): e0244934 doi: 10.1371/journal.pone.0244934
|
| 26 |
Fabian Benz, Andreas Bogen, Michael Praktiknjo, Christian Jansen, Carsten Meyer, Alexander Wree, Muenevver Demir, Sven Loosen, Mihael Vucur, Robert Schierwagen, Frank Tacke, Jonel Trebicka, Christoph Roderburg, Pavel Strnad. Serum levels of bone sialoprotein correlate with portal pressure in patients with liver cirrhosis. PLOS ONE 2020; 15(4): e0231701 doi: 10.1371/journal.pone.0231701
|